Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Idle

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Biochemical Pharmacology|July 1, 1982
Unequivocal synthesis and characterisation of dopamine 3- and 4-O-sulphatesB A Osikowska, J R Idle, F J Swinbourne, et al.
Lancet (London, England)|March 27, 1999
Genetic variation of CYP2A6, smoking, and risk of cancerS J London, J R Idle, A K Daly, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Influence of oxidation polymorphism on phenformin kinetics and dynamicsN S Oates, R R Shah, J R Idle, et al.
Toxicology|February 1, 1987
The relative importance of N-oxidation and N-demethylation in the metabolism of trimethylamine in manM Al-Waiz, S C Mitchell, J R Idle, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1979
Genetic evidence for the involvement of different oxidative mechanisms in drug oxidationL A Wakile, T P Sloan, J R Idle, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Insights into the mechanisms of ifosfamide encephalopathy: drug metabolites have agonistic effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and induce cellular acidification in mouse cortical neuronsJ Y Chatton, J R Idle, C B Vågbø, et al.
Pharmacogenetics|November 14, 1997
Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles CountyS J London, T Sullivan-Klose, A K Daly, et al.
Lancet (London, England)|June 18, 1983
Protecting poor metabolizers, a group at high risk of adverse drug reactionsJ R Idle, N S Oates, R R Shah, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1997
Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotypeM Armstrong, A K Daly, R Blennerhassett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Allelic association between the DRD2 TaqI A polymorphism and Parkinson's diseaseL Grevle, C Güzey, H Hadidi, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Biochemical Pharmacology|July 1, 1982
Unequivocal synthesis and characterisation of dopamine 3- and 4-O-sulphatesB A Osikowska, J R Idle, F J Swinbourne, et al.
Lancet (London, England)|March 27, 1999
Genetic variation of CYP2A6, smoking, and risk of cancerS J London, J R Idle, A K Daly, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Influence of oxidation polymorphism on phenformin kinetics and dynamicsN S Oates, R R Shah, J R Idle, et al.
Toxicology|February 1, 1987
The relative importance of N-oxidation and N-demethylation in the metabolism of trimethylamine in manM Al-Waiz, S C Mitchell, J R Idle, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1979
Genetic evidence for the involvement of different oxidative mechanisms in drug oxidationL A Wakile, T P Sloan, J R Idle, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Insights into the mechanisms of ifosfamide encephalopathy: drug metabolites have agonistic effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and induce cellular acidification in mouse cortical neuronsJ Y Chatton, J R Idle, C B Vågbø, et al.
Pharmacogenetics|November 14, 1997
Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles CountyS J London, T Sullivan-Klose, A K Daly, et al.
Lancet (London, England)|June 18, 1983
Protecting poor metabolizers, a group at high risk of adverse drug reactionsJ R Idle, N S Oates, R R Shah, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1997
Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotypeM Armstrong, A K Daly, R Blennerhassett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Allelic association between the DRD2 TaqI A polymorphism and Parkinson's diseaseL Grevle, C Güzey, H Hadidi, et al.
Pageof 20